Randomized, double-blind, Phase II Study of FOLFOX/Bevacizumab with MetMAb versus Placebo as First-Line Treatment for Patients with Metastatic Colorectal Cancer
Conditions
Colorectal Cancer
Trial Phase
Trial Purpose and Description
Trial Purpose
Participation Guidelines
- Age:
- 18 Years and older
- Gender:
- Both
Eligibility Criteria
- Sponsor:
- Genentech
- Dates:
- October 2011
- Last Updated:
- Study HIC#:
- 1108008917
Clinicaltrials.gov ID: Yale3509594
